Trametinib Dimethyl Sulfoxide and Venous thromboembolism
Result of checking the interaction of drug Trametinib Dimethyl Sulfoxide and disease Venous thromboembolism for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Venous thromboembolism can occur with trametinib. It is recommended to permanently discontinue the use of trametinib for life threatening pulmonary embolism and to withhold therapy for uncomplicated deep venous thrombosis and pulmonary embolism for up to 3 weeks or as clinically appropriate and if improved patients should resume treatment at a lower dose as clinically indicated. Care should be exercised when using this agent in patients at risk.
Generic Name: trametinib
Brand Name: Mekinist
Synonyms: Trametinib